CPL207280 | MedChemExpress (MCE)
CPL207280 is an orally active GPR40/FFA1 agonist with an antidiabetic effect. CPL207280 can effectively enhance glucose-stimulated insulin secretion and improve glucose tolerance in MIN6 pancreatic β-cells as well as in healthy Wistar Han rats and diabetic rat models. CPL207280 can be used for the research of type 2 diabetes[1][2].
| Trivial name | CPL207280 |
| Catalog Number | HY-160602 |
| Research Area | Metabolic Disease |
| CAS# | 2361497-72-3 |
| Purity | ≥98.0% |
| SMILES | OC(C[C@@H](C1=CC=C(C=C1)OC/C(C)=C(C)/C)C#CC)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/cpl207280.html |